MedSciences Capital logo

MedSciences Capital

Europe, Zuid-Holland, The Netherlands, The Hague

Description

MedSciences Capital (MSC) is a ven­ture cap­i­tal provider to early- and mid-stage com­pa­nies devel­op­ing inno­v­a­tive prod­ucts in the

Investor Profile

MedSciences Capital has made 7 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

  • Series Unknown (57%)
  • Series B (14%)
  • Series A (14%)
  • Seed (14%)

Country Focus

  • The Netherlands (86%)
  • Belgium (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Pharmaceutical
  • Health Diagnostics
  • Genetics
  • Therapeutics
  • Medical Device
  • Telehealth
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MedSciences Capital frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
BioGeneration Ventures
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
MP Healthcare Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
QF
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
NV NOM
Europe, Groningen, The Netherlands, Groningen
Co-Investments: 2
Kempen & Co
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1

What are some of recent deals done by MedSciences Capital?

Mucosis

Groningen, Groningen, The Netherlands

Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.

BiotechnologyHealth CareMedical
Series UnknownApr 29, 2014
Amount Raised: $6,900,000
Prosensa

Leiden, Zuid-Holland, The Netherlands

Prosensa provides RNA-based therapeutics for the treatment of genetic disorders, infections and cancers.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series UnknownJan 25, 2012
Amount Raised: $29,982,858
Net Medical

Houten, Utrecht, The Netherlands

Net Medical is a telemedicine solution provider.

Health CareMedicalTelehealth
SeedJan 1, 2011
Pronota

Ghent, Oost-Vlaanderen, Belgium

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.

BiotechnologyHealth CareHealth Diagnostics
Series BMay 19, 2010
Amount Raised: $1,852,552
Organ Assist

Groningen, Groningen, The Netherlands

Organ Assist is a medical technology company.

Health CareMedicalMedical Device
Series UnknownFeb 23, 2010
Amount Raised: $2,299,653
Mucosis

Groningen, Groningen, The Netherlands

Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.

BiotechnologyHealth CareMedical
Series ASep 10, 2007
Amount Raised: $4,140,164
Kiadis Pharma

Amsterdam, Noord-Holland, The Netherlands

Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.

BiopharmaBiotechnologyPharmaceutical
Series UnknownJun 26, 2007
Amount Raised: $20,200,442